SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED

Shandong Weigao Group Medical Polymer Company Limited

Equities

1066

CNE100000171

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. Other stock markets 03:08:28 2026-01-23 am EST			5-day change	1st Jan Change
5.130 ^HKD	-0.77%		-5.18%	+2.19%

Jan. 05	Shandong Weigao Group Finalizes Sale of Drug Packaging Arm to Affiliate	MT
Nov. 11	Weigao Group Medical Polymer Unit Forms JV Firm in Indonesia	MT

Shandong Weigao Group Medical Polymer Company Limited Reports Unaudited Revenue Results for the Third Quarter Ended 30 September 2025

Published on 11/03/2025 at 03:44 am EST

S&P Capital IQ

SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED

-0.77%

Shandong Weigao Group Medical Polymer Company Limited reported unaudited revenue results for the third quarter ended 30 September 2025. For the three months ended 30 September 2025, the Company recorded an unaudited
revenue of approximately RMB 3.26 billion, representing a year-on-year increase of approximately 2.6%.

Latest news about Shandong Weigao Group Medical Polymer Company Limited

Jan. 05	Shandong Weigao Group Finalizes Sale of Drug Packaging Arm to Affiliate	MT
Nov. 11	Weigao Group Medical Polymer Unit Forms JV Firm in Indonesia	MT
Nov. 10	Shandong Weigao Group Medical Polymer says unit enters joint venture with PT Oneject Indonesia	RE
Nov. 03	Weigao Group Medical Polymer's Revenue Jumps 2.6% in September Quarter	MT
Nov. 03	Shandong Weigao Group Medical Polymer posts quarterly revenue of about RMB 3.26 billion	RE
Nov. 03	Shandong Weigao Group Medical Polymer Company Limited Reports Unaudited Revenue Results for the Third Quarter Ended 30 September 2025	CI
25-10-31	Shandong Weigao Group Medical Polymer says Weigao Blood Purification to buy 100% equity in Wego Prefills	RE
25-10-20	Weigao Medical Affiliate Mulls Acquisition of Drug Packaging Arm; Shares Gain 1%	MT
25-10-17	Shandong Weigao Group Medical Polymer says Shandong Weigao Blood Purification Products Co to buy Shandong Wego Prefills Pharmaceutical Packaging Co	RE
25-10-17	Shandong Weigao Group Medical Polymer Company Limited Approves Interim Dividend for the Six Months Ended 30 June 2025, Payable on 21 November 2025	CI
25-10-16	Shandong Weigao Blood Purification Products Co., Ltd. entered into a non-legally binding letter of intent to acquire Shandong Wego Prefills Pharmaceutical Packaging Co., Ltd for CNY 10.8 billion.	CI
25-09-29	Shandong Weigao Group Medical Polymer Company Limited Announces Resignation of Yan Xia as Vice Chairman of the Board and A Non-Executive Director, Effective from 8 October 2025	CI
25-09-09	Shandong Weigao Buys Back Shares	MT
25-09-03	Weigao Group Medical Polymer Buys Back Shares	MT
25-08-27	Weigao Group's Profit Slides 9% in H1	MT
25-08-27	Shandong Weigao Group Medical Polymer Company Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-08-27	Shandong Weigao Group Medical Polymer Company Limited Proposes Interim Dividend for the Six Months Ended 30 June 2025, Payable on 21 November 2025	CI
25-08-27	Tranche Update on Shandong Weigao Group Medical Polymer Company Limited's Equity Buyback Plan announced on February 11, 2025.	CI
25-08-27	Tranche Update on Shandong Weigao Group Medical Polymer Company Limited's Equity Buyback Plan announced on May 27, 2025.	CI
25-07-15	Nomura Adjusts Shandong Weigao Group Medical Polymer's Price Target to HK$7.08 From HK$6.29, Keeps at Buy	MT
25-07-07	Shandong Weigao Group Medical Polymer Repurchases Shares	MT
25-06-25	Shandong Weigao Group Medical Polymer Buys Back Shares	MT
25-05-28	Shandong Weigao's Vice-Chairman Steps Down; Successor Named	MT
25-05-28	Shandong Weigao Group Medical Polymer Company Limited Announces Change of Vice Chairman, Effective 28 May 2025	CI
25-05-27	Shandong Weigao Group Medical Polymer Company Limited Approves Final Ordinary Cash Dividend for the Financial Year Ended 31 December 2024, Payable on 11 July 2025	CI

Chart Shandong Weigao Group Medical Polymer Company Limited

Duration

Period

Chart Shandong Weigao Group Medical Polymer Company Limited

1066: Dynamic Chart

Company Profile

Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of single-use medical devices. The Company operates six segments. Medical Device Products segment engaged in the production and sale of clinical care, medical testing, anesthesia and surgical related products and other consumables. Orthopaedic Products segment engaged in the production and sale of orthopaedic products, including tissue repair product line. Interventional Products segment engages in production and sale of tumor and blood vessel interventional instruments. Pharma Packaging Products segment includes production and sale of pre-filled syringes and flushing syringes. Blood Management Products segment includes production and sale of blood collection, irradiation, storage, separation and sterilization products. Others segment includes finance lease and factoring business.

Employees

13,063

Sector

Medical Equipment, Supplies & Distribution

Calendar

Mar. 30 - Q4 2025 Earnings Release (Projected)

More about the company